NCT04910633View on ClinicalTrials.gov

Medical Treatment of Solid Tumors at the Lyon University Hospital Cancer Institute During the First Wave of COVID-19 in France: A Conservative Approach

CompletedOBSERVATIONAL
Enrollment

44

Participants

Timeline

Start Date

December 2, 2020

Primary Completion Date

December 9, 2020

Study Completion Date

January 22, 2021

Conditions
CancerSolid TumorCovid19
Interventions
OTHER

COCA is an observational study based on retrospective data issued from patient medial file.

"The following parameters will be collected from the medical files of the patients involved in this study:~* Age~* Gender~* Cancer type~* Cancer Stage~* Cancer Treatment~* COVID-19 severity (based on chest X-Ray damage. Low ≤25%, Middle: between 25-50%, High above 50%)~* Living Status~* Attribution of Mortality to COVID status~* Comorbidities"

Trial Locations (1)

69 677

Lyon University Hospital Cancer Institute, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT04910633 - Medical Treatment of Solid Tumors at the Lyon University Hospital Cancer Institute During the First Wave of COVID-19 in France: A Conservative Approach | Biotech Hunter | Biotech Hunter